RT Book, Section
A1 Hoffman, Barbara L.
A1 Schorge, John O.
A1 Bradshaw, Karen D.
A1 Halvorson, Lisa M.
A1 Schaffer, Joseph I.
A1 Corton, Marlene M.
SR Print(0)
ID 1125290401
T1 Endometrial Cancer
T2 Williams Gynecology, 3e
YR 2016
FD 2016
PB McGraw-Hill Education
PP New York, NY
SN 978-0-07-184908-1
LK accessmedicine.mhmedical.com/content.aspx?aid=1125290401
RD 2024/04/20
AB In  the  United  States,  endometrial  cancer  is  the  most  common  gynecologic  malignancy.  Risk  factors  include  obesity  and  advancing  age.  As  these  factors  are  now  more  prevalent,  the  incidence  of  endometrial  cancer  continues  to  increase.  Fortunately,  patients  usually  seek  medical  attention  early  due  to  vaginal  bleeding,  and  endometrial  biopsy  leads  quickly  to  diagnosis.  The  primary  treatment  is  hysterectomy  with  bilateral  salpingo-oophorectomy  (BSO)  and  staging  lymphadenectomy  for  most  women.  Three  quarters  will  have  stage  I  disease  that  is  curable  by  surgery  alone.  Patients  with  more  advanced  disease  typically  require  postoperative  combination  chemotherapy,  radiotherapy,  or  both.